AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
Jun 23, 2011
30583_dirs_2011-06-23_50453a17-0642-4468-bed6-e5dd7fcb8d1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-06-22
Reporting Person: Wood Mark (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-22 | Common Stock | M | 1000 | — | Acquired | 21005 | Direct |
| 2011-06-22 | Common Stock | M | 937 | $14.39 | Acquired | 21942 | Direct |
| 2011-06-22 | Common Stock | M | 625 | $17.33 | Acquired | 22567 | Direct |
| 2011-06-22 | Common Stock | M | 83 | $17.86 | Acquired | 22650 | Direct |
| 2011-06-22 | Common Stock | S | 1645 | $25.9252 | Disposed | 21005 | Direct |
| 2011-06-23 | Common Stock | S | 371 | $25.555 | Disposed | 20634 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-22 | Stock Option (right to buy) | $14.39 | M | 937 | Disposed | 2019-05-11 | Common Stock (937) | Direct |
| 2011-06-22 | Stock Option (right to buy) | $17.33 | M | 625 | Disposed | 2017-06-06 | Common Stock (625) | Direct |
| 2011-06-22 | Stock Option (right to buy) | $17.86 | M | 83 | Disposed | 2028-12-16 | Common Stock (83) | Direct |
| 2011-06-22 | Restricted Stock Units | $0 | M | 1000 | Disposed | Common Stock (1000) | Direct |
Footnotes
F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted June 7, 2007.
F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 20, 2010.
F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $25.58 to $26.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4: The price in Column 4 is a weighted average price. The prices actually received ranged from $25.33 to $25.62. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
F6: Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.
F7: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.
F8: Original grant of restricted stock units vest 1/4th each on July 7, 2008, June 7, 2009, June 22, 2010 and June 22, 2011.